Phase 3 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific type of cancer called squamous cell carcinoma in the mouth, throat, voice box, or lower throat area, at any stage (T1–T4), and whose cancer has at least one of these features: cancer found in nearby lymph nodes, cancer growing along nerves, cancer found in blood or lymph vessels, or surgical margins that were very close to the cancer but not clearly affected
- People aged between 18 and 80 years old
- People who were in good general health and able to carry out daily activities without significant limitation at the time of surgery (confirm with trial site)
- People who are able and willing to give formal consent to take part in the trial
- People who are able to attend follow-up appointments over a longer period of time
Who may not be able to join:
- People whose surgery showed cancer at the edges of the removed tissue (positive margins) or cancer that has spread beyond the lymph node capsule
- People whose cancer is at an early stage (T1–T2), has not spread to lymph nodes, and does not have any of the specific risk features listed above
- People who have received or are receiving chemotherapy given before or at the same time as other treatments
- People whose cancer is not of the squamous cell type
- People whose cancer has spread to other parts of the body beyond the head and neck
- People who have another active cancer at the same time, outside of the mouth, throat, voice box, or lower throat area
- People who are pregnant or currently breastfeeding
- People who have previously had radiation treatment to the head or neck area
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dr. Aman Sharma, National cancer Institute, AIIMS, Jhajjar
Phone: +917018529339
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
loco-regional control at 24 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.